Search research articles
Contact Us
Filters
Showing results (21-30 of 134) with videos related to
Page
of 14
Sort By:
Methods and Findings in Experimental and Clinical Pharmacology
|
March 6, 2002
Biotinylation of antisense oligonucleotides does not alter lipofectin enhanced cellular uptake in prostate cancer cell lines
M Rubenstein, Y Mirochnik, L Slobodskoy, et al.
Urology
|
March 1, 1974
Antibodies to epithelium in benign prostatic hypertrophy and carcinoma of prostate. Exacerbation to hyperplasia and neoplasia and possible clue to cancer
R J Ablin, P Guinan, I M Bush
Medical Oncology (Northwood, London, England)
|
March 1, 1997
Enhanced expression of bcl-2 following antisense oligonucleotide mediated growth factor deprivation
M Rubenstein, P Chou, Y Mirochnik, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
March 6, 2003
Backbone modification alters the efficacy of antisense oligonucleotides directed against mRNA encoding either TGF-alpha or EGFR in the treatment of prostate cancer cell lines
M Rubenstein, L Slobodskoy, Y Mirochnik, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
March 26, 1999
Growth factor deprivation therapy of hormone insensitive prostate and breast cancers utilizing antisense oligonucleotides
M Rubenstein, Y Mirochnik, P Chou, et al.
Journal of the National Medical Association
|
December 1, 1991
Prostate cancer: the stage disadvantage in the black male
P V Targonski, P Guinan, C W Phillips
Journal of Surgical Oncology
|
April 1, 1997
Report of 337 patients with renal cell carcinoma emphasizing 110 with stage IV disease and review of the literature
P Guinan, D Stuhldreher, W Frank, et al.
Archivos Espanoles De Urologia
|
November 1, 1978
[Transuteral ureterorenoscopy]
S Z Muñóz, I M Bush, P Guinan
The Proceedings of the Institute of Medicine of Chicago
|
May 1, 1973
Carcinoembryonic antigen (CEA) in the plasma and urine of patients with urologic cancer
A Thitipraserth, R Ablin, I Bush, et al.
Clinical Physiology and Biochemistry
|
January 1, 1990
Effect of early and delayed difluoromethylornithine pretreatment upon cyclophosphamide chemotherapy
M Johnson, M Shaw, M Rubenstein, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 134) with videos related to
Sort By:
Page
of 14
Methods and Findings in Experimental and Clinical Pharmacology
|
March 6, 2002
Biotinylation of antisense oligonucleotides does not alter lipofectin enhanced cellular uptake in prostate cancer cell lines
M Rubenstein, Y Mirochnik, L Slobodskoy, et al.
Urology
|
March 1, 1974
Antibodies to epithelium in benign prostatic hypertrophy and carcinoma of prostate. Exacerbation to hyperplasia and neoplasia and possible clue to cancer
R J Ablin, P Guinan, I M Bush
Medical Oncology (Northwood, London, England)
|
March 1, 1997
Enhanced expression of bcl-2 following antisense oligonucleotide mediated growth factor deprivation
M Rubenstein, P Chou, Y Mirochnik, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
March 6, 2003
Backbone modification alters the efficacy of antisense oligonucleotides directed against mRNA encoding either TGF-alpha or EGFR in the treatment of prostate cancer cell lines
M Rubenstein, L Slobodskoy, Y Mirochnik, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
March 26, 1999
Growth factor deprivation therapy of hormone insensitive prostate and breast cancers utilizing antisense oligonucleotides
M Rubenstein, Y Mirochnik, P Chou, et al.
Journal of the National Medical Association
|
December 1, 1991
Prostate cancer: the stage disadvantage in the black male
P V Targonski, P Guinan, C W Phillips
Journal of Surgical Oncology
|
April 1, 1997
Report of 337 patients with renal cell carcinoma emphasizing 110 with stage IV disease and review of the literature
P Guinan, D Stuhldreher, W Frank, et al.
Archivos Espanoles De Urologia
|
November 1, 1978
[Transuteral ureterorenoscopy]
S Z Muñóz, I M Bush, P Guinan
The Proceedings of the Institute of Medicine of Chicago
|
May 1, 1973
Carcinoembryonic antigen (CEA) in the plasma and urine of patients with urologic cancer
A Thitipraserth, R Ablin, I Bush, et al.
Clinical Physiology and Biochemistry
|
January 1, 1990
Effect of early and delayed difluoromethylornithine pretreatment upon cyclophosphamide chemotherapy
M Johnson, M Shaw, M Rubenstein, et al.
Page
of 14